Qube Research & Technologies LTD Pliant Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$18.12 - $30.56 $1.85 Million - $3.11 Million	-101,850 Reduced 57.91%	74,025 $1.34 Million
Q1 2023 May 15, 2023	BUY	$18.73 - $36.26 $1.85 Million - $3.58 Million	98,805 Added 128.2%	175,875 $4.68 Million
Q4 2022 Feb 14, 2023	BUY	$17.0 - $25.43 $852,873 - $1.28 Million	50,169 Added 186.49%	77,070 $1.49 Million
Q3 2022 Nov 14, 2022	BUY	$7.67 - $24.23 $103,100 - $325,699	13,442 Added 99.87%	26,901 $562,000
Q2 2022 Aug 15, 2022	BUY	$4.11 - $8.75 $55,316 - $117,766	13,459 New	13,459 $108,000

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.